⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL164603 | 1.00 | — | — | |
| SCHEMBL164602 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL20532011 | 0.97 | — | — | |
| Acetaldehyde SCHEMBL27601442 | 0.89 | MTNR1A (0.33) | — | |
| Acetamide SCHEMBL5182199 | 0.89 | BLM (0.35) | — | |
| Acetamide SCHEMBL5182479 | 0.89 | BLM (0.35) | — | |
| SCHEMBL17865758 | 0.82 | CRBN (0.59) | — | |
| SCHEMBL24553533 | 0.76 | — | — | |
| SCHEMBL16691770 | 0.74 | — | — | |
| SCHEMBL1559274 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106631962-B | A kind of preparation method of (S)-Oxiracetam | 南京帝昌医药科技有限公司 | 2019-01-22 | — | — | CN | claimed |
| CN-106349145-B | A method of preparing nootropics (S)-Oxiracetam | 徐敏 | 2018-11-20 | — | — | CN | claimed |
| CN-106349145-A | Method for preparing intelligence-improving medicine (S)-oxiracetam | 青岛云天生物技术有限公司 | 2017-01-25 | — | — | CN | claimed |
| JP-10165195-A | — | — | None | — | — | JP | disclosed |
| CN-122094678-A | AP 2-related kinase 1 inhibitors and uses thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122055358-A | GPR65 small molecule regulator and preparation method and application thereof | 四川大学 | 2026-05-15 | — | — | CN | disclosed |
| EP-4709720-A1 | INHIBITORS AND DEGRADERS OF PIP4K PROTEIN | Larkspur Biosciences, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| US-12545640-B2 | Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof | SANOFI (FR) | 2026-02-10 | — | — | US | disclosed |
| EP-4680601-A1 | PYRIDAZINE COMPOUNDS, THEIR PREPARATION, AND THEIR THERAPEUTIC USES | Sanofi (FR) | 2026-01-21 | — | — | EP | disclosed |
| CN-120247763-B | Preparation method of pra Lu Gelie statin intermediate | 济南康桥医药科技有限公司 | 2025-12-26 | — | — | CN | disclosed |
| US-20250270222-A1 | AP2 ASSOCIATED KINASE 1 INHIBITORS AND USES THEREOF | SATELLOS BIOSCIENCE INC. (CA) | 2025-08-28 | — | — | US | disclosed |
| EP-0474243-B1 | 1-Methylcarbapenem derivatives and process for preparation thereof | TANABE SEIYAKU CO (JP) | 1998-04-01 | — | — | EP | disclosed |
| EP-0829472-A1 | IMPROVED PROCESS FOR PRODUCING 4-HYDROXY-2-PYRROLIDONE | DAISO CO., LTD. (JP) | 1998-03-18 | — | — | EP | disclosed |
| EP-0787718-A1 | Process for preparing optically active 4-hydroxy-2-pyrrolidone | Takasago International Corporation (JP) | 1997-08-06 | — | — | EP | disclosed |
| CN-1033455-C | 1-methylcarbapenem derivatives and process for preparation thereof | TANABE SEIYAKU CO (JP) | 1996-12-04 | — | — | CN | disclosed |
| US-5424306-A | Storage stable | SANKYO COMPANY, LIMITED (JP) | 1995-06-13 | — | — | US | disclosed |
| US-5208348-A | Intermediates for thienamycin derivatives | TANABE SEIYAKU CO., LTD. (JP) | 1993-05-04 | — | — | US | disclosed |
| US-5153187-A | Microbiocides having stability against dehydropeptidase and high absorrbability by oral administration | TANABE SEIYAKU CO., LTD. (JP) | 1992-10-06 | — | — | US | disclosed |
| CN-1060093-A | 1-methylcarbapenem derivatives and preparation method thereof | TANABE SEIYAKU CO (JP) | 1992-04-08 | — | — | CN | disclosed |
| EP-0474243-A1 | 1-Methylcarbapenem derivatives and process for preparation thereof | TANABE SEIYAKU CO., LTD. (JP) | 1992-03-11 | — | — | EP | disclosed |